Oral vaccination. Identification of classes of proteins that provoke an immune response upon oral feeding.
about
M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B.A single point mutation within the coding sequence of cholera toxin B subunit will increase its expression yieldAntibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugatesDifferential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of humansSystemic and mucosal immune responses after intranasal administration of recombinant Mycobacterium bovis bacillus Calmette-Guérin expressing glutathione S-transferase from Schistosoma haematobium.Mucosal immunity and tolerance: relevance to vaccine development.Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development.The immune responses to bacterial antigens encountered in vivo at mucosal surfaces.Polymeric display of immunogenic epitopes from herpes simplex virus and transmissible gastroenteritis virus surface proteins on an enteroadherent fimbria.Oral administration of influenza vaccine in combination with the adjuvants LT-K63 and LT-R72 induces potent immune responses comparable to or stronger than traditional intramuscular immunizationNontypeable Haemophilus influenzae: pathogenesis and preventionEffects of soybean agglutinin on body composition and organ weights in rats.Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues.Difference between bacterial and food antigens in mucosal immunogenicity.A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteins.Anticarrier immunity suppresses the antibody response to polysaccharide antigens after intranasal immunization with the polysaccharide-protein conjugate.Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina.Targeted delivery of antigen to hamster nasal lymphoid tissue with M-cell-directed lectinsUse of targeting agents to increase uptake and localization of drugs to the intestinal epithelium.Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance.Delivery systems and adjuvants for oral vaccines.Mucosal immunization with filamentous hemagglutinin protects against Bordetella pertussis respiratory infectionInduction of mucosal immune responses against a heterologous antigen fused to filamentous hemagglutinin after intranasal immunization with recombinant Bordetella pertussis.Targeting receptors, transporters and site of absorption to improve oral drug delivery.Comparison of serum humoral responses induced by oral immunization with the hepatitis B virus core antigen and the cholera toxin B subunitOral Rabies Vaccine Design for Expression in Plants.Targeting aminopeptidase N, a newly identified receptor for F4ac fimbriae, enhances the intestinal mucosal immune response.Receptor-dependent immune responses in pigs after oral immunization with F4 fimbriaeImmune responses to novel Escherichia coli and Salmonella typhimurium vectors that express colonization factor antigen I (CFA/I) of enterotoxigenic E. coli in the absence of the CFA/I positive regulator cfaR.Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models.Implications of antinutritional components in soybean foods.Clostridium difficile toxin A carboxyl-terminus peptide lacking ADP-ribosyltransferase activity acts as a mucosal adjuvant.History of oral tolerance and mucosal immunity.Absorption and presentation of antigens by epithelial cells of the small intestine: hypotheses and predictions relating to the pathogenesis of coeliac disease.Cholera toxin B subunit as transmucosal carrier-delivery and immunomodulating system for induction of antiinfectious and antipathological immunity.Intestinal tissue distribution and epithelial transport of the oral immunogen LTB, the B subunit of E. coli heat-labile enterotoxin.Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide.Expression of rabies glycoprotein and ricin toxin B chain (RGP-RTB) fusion protein in tomato hairy roots: a step towards oral vaccination for rabies.Crystal structure of cholera toxin B-pentamer bound to receptor GM1 pentasaccharide.Whole cholera toxin and B subunit act synergistically as an adjuvant for the mucosal immune response of mice to keyhole limpet haemocyanin.
P2860
Q33307430-5F6A220D-F922-4F8F-819A-825AF7C989BAQ33722430-5AB4D861-179E-46AA-950F-DF7F362D7B6BQ33750130-2DD3A79D-E4BA-4978-B33C-D66B673364C9Q33756767-18302E4A-63B7-4440-962D-687D083FCA23Q33768306-FF01D6BE-4D12-4523-B055-96DB329BFE28Q33776172-D6B9C053-8165-42E7-AA3D-D21E3CC3B80AQ33831194-CFD3BC20-FAB8-4484-9CC4-1A6C7520438BQ33955531-C0F91AA1-1846-42EC-B5CD-83DD112A6F90Q33997509-13170A71-8934-4D02-919D-5119F659E758Q33999182-5046B4C5-1200-4D66-BBE9-9A4F024B43D9Q34009998-1897E021-8B31-4956-9A4C-47215CC7E6A2Q34532255-510FE508-D46C-476F-8FC7-9A9B19D58C70Q35093806-E038368C-38E1-4BF0-B80F-BE1B84E7FF1AQ35101571-D8ED73B7-C1A8-4E43-8EE4-F7277E9B42CFQ35414871-22358694-2F0D-4B7E-ACC8-01859B8AE83DQ35546011-57F078F4-34B4-4D66-8277-208535D1FF4DQ35550710-D5D7A8AB-E1ED-4DFE-AFAB-29A02999F870Q35556883-C5D14398-7F6E-431C-8D0A-BEEC83F5AE19Q35809229-1F6252D9-76DE-4763-9B0B-82FDBBE2B4B2Q35878983-8A6B8B70-91CE-49B0-8B32-3B00A7626BBFQ36640326-98C8FCBD-DA99-4CAC-B0FF-BE48A3BB2C72Q36943283-A672A3A9-C7B0-4093-AE15-934F9332C822Q37451865-C4200E52-B30C-47DF-B104-E283368F9D5FQ37928909-3C6E6073-7669-45FD-A07E-27EB55B60F97Q38606892-91E5CD66-9CA0-49A8-830F-20A1D39C05CBQ38778390-4D2C2AFA-2889-4581-843D-F5BBEE30C870Q39336508-515F4B2B-0F6C-4155-B5A5-C413BAEF6C43Q39509512-1649CED9-A2F2-4730-9BCB-93EABFF5D4C8Q39823811-DD87D8E9-0FB7-48BA-A396-D5B5308F92C1Q40267400-EEB72388-F134-4C72-B473-72B29FA9EB4CQ40732398-8522B606-C93E-4250-B0B1-30D869174A54Q40763960-C8BA304C-1D4E-4641-AF49-50D774DEB6C1Q40949749-1ED4A0EC-12F8-4ED5-9446-E623B8A05958Q40966549-3C2D19DA-20B8-450F-9679-1657DE4BA192Q40976342-2BAEBAC5-337B-4D71-8B22-8FB59838EA75Q41586562-FE75225D-EA2E-410A-A81B-41F22361EE20Q42061242-9ED5E306-CCC2-460B-B7B2-AD59E7B12A8BQ42176690-405E6A80-3619-4809-9CDF-EB7B9E3951A9Q42844055-5F51656F-99E1-479E-9CBC-4F8269195020Q43484125-01F7350B-B8D6-4FDE-92EB-A23384F34AA8
P2860
Oral vaccination. Identification of classes of proteins that provoke an immune response upon oral feeding.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Oral vaccination. Identificati ...... ne response upon oral feeding.
@ast
Oral vaccination. Identificati ...... ne response upon oral feeding.
@en
type
label
Oral vaccination. Identificati ...... ne response upon oral feeding.
@ast
Oral vaccination. Identificati ...... ne response upon oral feeding.
@en
prefLabel
Oral vaccination. Identificati ...... ne response upon oral feeding.
@ast
Oral vaccination. Identificati ...... ne response upon oral feeding.
@en
P2860
P356
P1476
Oral vaccination. Identificati ...... ne response upon oral feeding.
@en
P2093
Russell-Jones GJ
de Aizpurua HJ
P2860
P304
P356
10.1084/JEM.167.2.440
P407
P577
1988-02-01T00:00:00Z